Literature DB >> 18546035

Gallbladder abnormalities in carcinoma of pancreatic head: findings on MR imaging.

Xiao Ming Zhang1, Donald G Mitchell, Jae Ho Byun, Sachit K Verma, Diane Bergin, Agnes Witkiewicz.   

Abstract

BACKGROUND: Our objective is to study the gallbladder abnormalities on MR images associated with carcinoma of the pancreatic head.
METHODS: Thirty-six patients who had surgical resection of pancreatic head carcinoma were retrospectively analyzed regarding the appearance of the tumor and gallbladder on MR imaging performed within one month before surgery. The changes of the gallbladder wall, and the dimension of the gallbladder, cystic duct, pericholecystic region, and common bile duct (CBD) on MR imaging were noted.
RESULTS: About 92% (33/36) of patients had at least one gallbladder abnormality on MR imaging, including thickened gallbladder wall (58%), gallbladder wall striation (19%), gallbladder wall severe enhancement (44%), enlarged gallbladder (33%), gallbladder stone (19%), dilatation of cystic duct (67%), focally increased liver parenchymal enhancement adjacent to the gallbladder (19%), and pericholecystic fluid (11%). 64% of patients had dilated CBD. The diameter of the cystic duct was correlated with those of the CBD (r = 0.45, P < 0.01) and gallbladder (r = 0.56, P < 0.0001). Enlarged gallbladder, dilatation of the cystic duct, and CBD were correlated with chronic cholecystitis.
CONCLUSION: Most patients with pancreatic head carcinoma show gallbladder abnormalities on MR imaging. Cystic duct dilatation follows CBD dilatation and is the primary cause for dilated gallbladder and chronic cholecystitis in carcinoma of pancreatic head.

Entities:  

Mesh:

Year:  2009        PMID: 18546035     DOI: 10.1007/s00261-008-9422-6

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  1 in total

1.  Hepatic abnormal perfusion visible by magnetic resonance imaging in acute pancreatitis.

Authors:  Wei Tang; Xiao-Ming Zhang; Zhao-Hua Zhai; Nan-Lin Zeng
Journal:  World J Radiol       Date:  2013-12-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.